News | February 19, 2022
UAE to recognise Indian pharma products within three months
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
The insights collected by the app will support the pharmaceutical industry’s efforts to further improve patients’ lives by providing actionable data on patients’ individual experiences
Evonik invests in start-up to improve patient recovery after open-chest surgery
The speakers for the e-conference are: Dr. Mukund Chorgade, President/CSO, THINQ Pharma; Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance; Jayaseelan J., National Vice President (Industry Division), Indian Pharmaceutical Association; Spandan Mishra who is Director- Sales, Customer Service & Logistics for Evonik India, Nepal & Sri Lanka region; Dr. Kommu Nagaiah, Chief Scientist & Head, CSIR-IICT; Govind K. Jaju, Partner, Suingora Consulting; nd Pravin Prashant, Executive Editor, Indian Pharma Post & Editor, Indian Chemical News.
It will open new frontier for south-to-south collaboration and innovation transfer
Key takeaways of recent quarter & conference call highlights
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
